A pioneering international study that accelerates the inclusion of adults with Down Syndrome in clinical trials is starting at the Alzheimer-Down Unit of the Hospital de Sant Pau and the Fundació Catalana de Síndome de Down in Barcelona.
The Trial Ready Cohort-Down Syndrome (TRC-DS), a new international study funded by the US National Institutes of Health (NIH), aims to better understand the link between Alzheimer’s disease and Down syndrome. Nine out of ten people with Down syndrome develop dementia due to Alzheimer’s disease throughout their lives and the scientific community believes that this population could be key to finding treatments that cure this disease.
At the Alzheimer-Down Unit of the Hospital de Sant Pau and the Fundació Catalana de Síndome de Down in Barcelona, we have recently started the study thanks to 5 volunteers and the support of their families. All of them are already part of the global TRC-DS community that will bring together 120 volunteers in Europe and the USA who could quickly opt to be included in clinical trials that will be launched in the future.
We are honored to be the only Spanish-speaking center in the study, helping the inclusion of participants from diverse backgrounds. We invite you all to participate.